AAAAAA
Results: 26-50/314
Authors:
FUNAKOSHI Y
FUJITA S
FUCHINOUE S
AGISHI T
OTA K
Citation: Y. Funakoshi et al., NEO RED-CELL AS AN ORGAN PRESERVATION SOLUTION, Artificial cells, blood substitutes, and immobilization biotechnology, 25(4), 1997, pp. 407-416
Authors:
OGATA Y
GOTO H
KIMURA T
FUKUI H
Citation: Y. Ogata et al., DEVELOPMENT OF NEO RED-CELLS (NRC) WITH THE ENZYMATIC REDUCTION SYSTEM OF METHEMOGLOBIN, Artificial cells, blood substitutes, and immobilization biotechnology, 25(4), 1997, pp. 417-427
Authors:
CHANG TMS
Citation: Tms. Chang, THE PASSING OF A PIONEER IN PERFLUOROCARBON BLOOD SUBSTITUTES, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 7-7
Authors:
NOTH U
MORRISSEY SP
DEICHMANN R
JUNG S
ADOLF H
HAASE A
LUTZ J
Citation: U. Noth et al., PERFLUORO-15-CROWN-5-ETHER LABELED MACROPHAGES IN ADOPTIVE TRANSFER EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 243-254
Authors:
EDWARDS CM
LOWE KC
ROLKE W
GEISTER U
REUTER P
MEINERT H
Citation: Cm. Edwards et al., EFFECTS OF A NOVEL PERFLUOROCARBON EMULSION ON NEUTROPHIL CHEMILUMINESCENCE IN HUMAN WHOLE-BLOOD IN-VITRO, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 255-260
Authors:
LOWE KC
ANTHONY P
WARDROP J
DAVEY MR
POWER JB
Citation: Kc. Lowe et al., PERFLUOROCHEMICALS AND CELL BIOTECHNOLOGY, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 261-274
Authors:
SEN AP
DONG YM
GULATI A
Citation: Ap. Sen et al., EFFECT OF DIASPIRIN CROSS-LINKED HEMOGLOBIN ON SYSTEMIC AND REGIONAL BLOOD-CIRCULATION IN PREGNANT RATS, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 275-288
Authors:
KIM MS
KIM HW
SWEENEY JD
GREENBURG AG
Citation: Ms. Kim et al., DECREASED WHOLE-BLOOD FACTOR-IX ACTIVITY FOLLOWING HEMODILUTION WITH HEMOGLOBIN A-ZERO IN-VITRO, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 289-295
Authors:
RUNGE TM
MCGINITY JW
FRISBEE SE
BRICENO JC
OTTMERS SE
CALHOON JH
HANTLER CB
KORVICK DL
YBARRA JR
Citation: Tm. Runge et al., ENHANCEMENT OF BRAIN PO(2) DURING CARDIOPULMONARY BYPASS USING A HYPEROSMOLAR OXYGEN-CARRYING SOLUTION, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 297-308
Authors:
THOMAS M
MATHESONURBAITIS B
KWANSA H
BUCCI E
FRONTICELLI C
Citation: M. Thomas et al., INTRODUCTION OF NEGATIVE CHARGES TO A CROSS-LINKED HEMOGLOBIN - LACK OF EFFECT ON PLASMA HALF TIME, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 309-314
Authors:
MILES PJ
LANGLEY KV
STACEY CJ
TALARICO TL
Citation: Pj. Miles et al., DETECTION OF RESIDUAL POLYETHYLENE-GLYCOL DERIVATIVES IN PYRIDOXYLATED-HEMOGLOBIN-POLYOXYETHYLENE CONJUGATE, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 315-326
Authors:
EDWARDS CM
LOWE KC
TRABELSI H
LUCAS P
CAMBON A
Citation: Cm. Edwards et al., NOVEL FLUORINATED SURFACTANTS FOR PERFLUOROCHEMICAL EMULSIFICATION - BIOCOMPATIBILITY ASSESSMENTS OF GLYCOSIDIC AND POLYOL DERIVATIVES, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 327-333
Authors:
CHANG TMS
Citation: Tms. Chang, RECENT AND FUTURE-DEVELOPMENTS IN MODIFIED HEMOGLOBIN AND MICROENCAPSULATED HEMOGLOBIN AS RED-BLOOD-CELL SUBSTITUTES, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 1-24
Authors:
GREENBURG AG
KIM HW
Citation: Ag. Greenburg et Hw. Kim, USE OF DONOR BLOOD IN THE SURGICAL SETTING - POTENTIALS FOR APPLICATION OF BLOOD SUBSTITUTES, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 25-29
Authors:
TAKEOKA S
OHGUSHI T
SAKAI H
KOSE T
NISHIDE H
TSUCHIDA E
Citation: S. Takeoka et al., CONSTRUCTION OF ARTIFICIAL METHEMOGLOBIN REDUCTION SYSTEMS IN HB VESICLES, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 31-41
Authors:
RIESS JG
KRAFFT MP
Citation: Jg. Riess et Mp. Krafft, ADVANCED FLUOROCARBON-BASED SYSTEMS FOR OXYGEN AND DRUG-DELIVERY, ANDDIAGNOSIS, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 43-52
Authors:
SEKIGUCHI S
Citation: S. Sekiguchi, THE IMPACT OF RED-CELL SUBSTITUTES ON THE BLOOD SERVICE IN JAPAN, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 53-60
Authors:
DEFIGUEIREDO LFP
ELGJO GI
MATHRU M
SILVA MRE
KRAMER GC
Citation: Lfp. Defigueiredo et al., HYPERTONIC ACETATE-ALPHA-ALPHA-HEMOGLOBIN FOR SMALL-VOLUME RESUSCITATION OF HEMORRHAGIC-SHOCK, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 61-73
Authors:
BARVE A
SEN AP
SAXENA PR
GULATI A
Citation: A. Barve et al., DOSE-RESPONSE EFFECT OF DIASPIRIN CROSS-LINKED HEMOGLOBIN (DCLHB) ON SYSTEMIC HEMODYNAMICS AND REGIONAL BLOOD-CIRCULATION IN RATS, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 75-84
Authors:
KUMAR A
SEN AP
SAXENA PR
GULATI A
Citation: A. Kumar et al., RESUSCITATION WITH DIASPIRIN CROSS-LINKED HEMOGLOBIN INCREASES CEREBRAL AND RENAL BLOOD PERFUSION IN HEMORRHAGED RATS, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 85-94
Authors:
COLE DJ
MCKAY L
JACOBSEN WK
DRUMMOND JC
PATEL PM
Citation: Dj. Cole et al., EFFECT OF SUBARACHNOID ADMINISTRATION OF ALPHA-ALPHA DIASPIRIN CROSS-LINKED HEMOGLOBIN ON CEREBRAL BLOOD-FLOW IN RATS, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 95-104
Authors:
HANZAWA K
OHZEKI H
MORO H
EGUCHI S
NAKAJIMA T
MAKIFUCHI T
MIYASHITA K
NISHIURA M
NARITOMI H
Citation: K. Hanzawa et al., EFFECTS OF PARTIAL BLOOD REPLACEMENT WITH PYRIDOXALATED HEMOGLOBIN POLYOXYETHYLENE CONJUGATE SOLUTION ON TRANSIENT CEREBRAL-ISCHEMIA IN GERBIL, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 105-114
Authors:
ULATOWSKI JA
ASANO Y
KOEHLER RC
Citation: Ja. Ulatowski et al., SUSTAINED ENDOTHELIAL-DEPENDENT DILATION IN PIAL ARTERIOLES AFTER CROSS-LINKED HEMOGLOBIN TRANSFUSION, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 115-120
Authors:
KIM HW
GREENBURG AG
Citation: Hw. Kim et Ag. Greenburg, FERROUS HEMOGLOBIN SCAVENGING OF ENDOTHELIUM-DERIVED NITRIC-OXIDE IS A PRINCIPAL MECHANISM FOR HEMOGLOBIN MEDIATED VASOACTIVITIES IN ISOLATED RAT THORACIC AORTA, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 121-133
Authors:
TAI J
KIM HW
Citation: J. Tai et Hw. Kim, ENDOTHELIN-1 IS NOT INVOLVED IN HEMOGLOBIN ASSOCIATED VASOACTIVITIES, Artificial cells, blood substitutes, and immobilization biotechnology, 25(1-2), 1997, pp. 135-140